Millennium Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Millennium Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,587	Closed	-$667K	–	4358
2017 Q4	$667K	Buy	14,587 +77	+0.5%	+$3.84K	﹤0.01%	2952
2017 Q3	$651K	Sell	14,510 -414,458	-97%	-$14.1M	﹤0.01%	2724
2017 Q2	$12.8M	Buy	428,968 +401,141	+1,442%	+$9.9M	0.02%	914
2017 Q1	$617K	Buy	+27,827	New	+$597K	﹤0.01%	2693
2016 Q2	–	Sell	-259,822	Closed	-$9.9M	–	3834
2016 Q1	$9.9M	Buy	259,822 +253,586	+4,066%	+$8.84M	0.02%	841
2015 Q4	$274K	Buy	6,236 +536	+9%	+$26.6K	﹤0.01%	2943
2015 Q3	$232K	Sell	5,700 -19,310	-77%	-$847K	﹤0.01%	3051
2015 Q2	$1.33M	Buy	+25,010	New	+$1.33M	﹤0.01%	2132
2015 Q1	–	Sell	-110,410	Closed	-$5.77M	–	4377
2014 Q4	$5.77M	Buy	+110,410	New	+$4.94M	0.01%	1291

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Millennium Management's JUNO Position: Q1 2018 in Review

Millennium Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 14,587 shares — an estimated $667K sold.

Millennium Management first reported a position in JUNO in Q4 2014 and held it in 9 quarters. The position peaked at $12.8M in Q2 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Millennium Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Millennium Management sold 14,587 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $667K.
Millennium Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
Millennium Management's Juno Therapeutics, Inc. position peaked at $12.8M in Q2 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.